EXC
56
-2
SJM
68
-2
EBAY
45
20
TXT
65
-3
EMN
30
-3
UHS
50
-4
SLB
67
-2
DG
40
-2
BAC
33
-2
DO
51
-2
GM
29
-3
MRO
43
-4
AMP
47
-3
FOXA
35
-2
INTC
33
-3
WAT
48
-2
STT
40
-4
ABT
30
-5
NWS
16
-3
MMC
46
-4
EXC
56
-2
SJM
68
-2
EBAY
45
20
TXT
65
-3
EMN
30
-3
UHS
50
-4
SLB
67
-2
DG
40
-2
BAC
33
-2
DO
51
-2
GM
29
-3
MRO
43
-4
AMP
47
-3
FOXA
35
-2
INTC
33
-3
WAT
48
-2
STT
40
-4
ABT
30
-5
NWS
16
-3
MMC
46
-4
Financhill
Back

Cabaletta Bio Quote, Financials, Valuation and Earnings

How He Bagged One Of The Top Trading Records

Click to see this exclusive sit-down interview
Sell
45

CABA
Cabaletta Bio

Last Price:
7.42
Seasonality Move:
-19.8%

7 Day Trial

ALL ACCESS PASS

$ 7

A 100% Win Rate In 2022

Click to see this exclusive sit-down interview

Cabaletta Bio Price Quote

$7.42
-0.05 (-0.67%)
(Updated: March 23, 2023 at 11:00 PM ET)

Cabaletta Bio Key Stats

Sell
45
Cabaletta Bio (CABA) is a Sell
Day range:
$7.46 - $8.28
52-week range:
$0.59 - $12.88
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
2.24%
Volume:
181.9K
Avg. volume:
485.6K
1-year change:
229.07%
Market cap:
$234.1M
Revenue:
$0
EPS:
$-1.81

How Much Does Cabaletta Bio Make?

Data Unavailable

Is Cabaletta Bio Growing As A Company?

Data Unavailable

Cabaletta Bio Stock Price Performance

  • Did Cabaletta Bio Stock Go Up Last Month?
    Cabaletta Bio share price went down by -12.63% last month
  • Did CABA's Share Price Rise Over The Last Year?
    CABA share price rose by 229.07% over the past 1 year

What Is Cabaletta Bio 52-Week High & Low?

Cabaletta Bio Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Cabaletta Bio?

  • How Much Debt Does Cabaletta Bio Have?
    Total long term debt quarterly is $0
  • How Much Cash Does Cabaletta Bio Have?
    Cash and short term investments quarterly total is $106.5M
  • What Is Cabaletta Bio’s Book Value Per Share?
    Book value per share is 3.55

Is Cabaletta Bio Cash Flow Positive?

  • What Is CABA Cash Flow From Operations?
    Cash flow from operations (TTM) is -$46.4M
  • What Is Cabaletta Bio’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $33M
  • What Is Cabaletta Bio’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$27.2M

Cabaletta Bio Return On Invested Capital

Data Unavailable

Cabaletta Bio Earnings Date & Stock Price

Cabaletta Bio Competitors

  • Who Are Cabaletta Bio's Competitors?
    Below is a list of companies who compete with Cabaletta Bio or are related in some way:
    • BioVie Inc (BIVI)
    • Bellicum Pharmaceuticals Inc (BLCM)
    • Eloxx Pharmaceuticals Inc (ELOX)
    • Homology Medicines Inc (FIXX)
    • Paratek Pharmaceuticals Inc (PRTK)

Cabaletta Bio Dividend Yield

Data Unavailable

Cabaletta Bio Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -19.08%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 5
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 14.17
Upside from Last Price: 89.65%

Major Shareholders

  • How many CABA shares are owned by institutional investors?
    38.6M CABA shares are owned by institutional investors
  • How many CABA shares are owned by insiders?
    1.2M CABA shares are owned by insiders